Masoud H. Manjili Department of Microbiology & Immunology Virginia Commonwealth University- Massey Cancer Center Biography Publications Institution JoVE Articles Masoud H. Manjili has not added a biography. If you are Masoud H. Manjili and would like to personalize this page please email our Author Liaison for assistance. Publications CD44(+)/CD24(-/low) Cancer Stem/progenitor Cells Are More Abundant in Triple-negative Invasive Breast Carcinoma Phenotype and Are Associated with Poor Outcome Human Pathology. Mar, 2012 | Pubmed ID: 21835433 A Signature of Immune Function Genes Associated with Recurrence-free Survival in Breast Cancer Patients Breast Cancer Research and Treatment. Feb, 2012 | Pubmed ID: 21479927 Suppression of Antigen-specific CD4(+) T Cell Activation by SRA/CD204 Through Reducing the Immunostimulatory Capability of Antigen-presenting Cell Journal of Molecular Medicine (Berlin, Germany). Nov, 2011 | Pubmed ID: 22083206 Favorable Outcomes in Patients with High Donor-Derived T Cell Count After In Vivo T Cell-Depleted Reduced-Intensity Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2011 | Pubmed ID: 22005648 Distinct Signatures of the Immune Responses in Low Risk Versus High Risk Neuroblastoma Journal of Translational Medicine. 2011 | Pubmed ID: 21978632 Targeting the Immunoregulator SRA/CD204 Potentiates Specific Dendritic Cell Vaccine-induced T-cell Response and Antitumor Immunity Cancer Research. Nov, 2011 | Pubmed ID: 21914786 An Immunologic Portrait of Cancer Journal of Translational Medicine. 2011 | Pubmed ID: 21875439 Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy Against Breast Cancer in the FVBN202 Transgenic Mouse Journal of Immunology (Baltimore, Md. : 1950). Jul, 2011 | Pubmed ID: 21670315 Prostate-derived Ets Transcription Factor (PDEF) is a Potential Prognostic Marker in Patients with Prostate Cancer The Prostate. Aug, 2011 | Pubmed ID: 21656828 Comment on "Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses" Journal of Immunology (Baltimore, Md. : 1950). Jun, 2011 | Pubmed ID: 21597038 Revisiting Cancer Immunoediting by Understanding Cancer Immune Complexity The Journal of Pathology. May, 2011 | Pubmed ID: 21480229 Tumor Escape and Progression of HER-2/neu Negative Breast Cancer Under Immune Pressure Journal of Translational Medicine. 2011 | Pubmed ID: 21453513 Prostate-derived Ets Transcription Factor (PDEF) is a Potential Prognostic Marker in Patients with Prostate Cancer The Prostate. Jan, 2011 | Pubmed ID: 21229552 Adoptive Cell Therapy of Prostate Cancer Using Female Mice-derived T Cells That React with Prostate Antigens Cancer Immunology, Immunotherapy : CII. Mar, 2011 | Pubmed ID: 21088965 CD4+ T Cells Inhibit the Neu-specific CD8+ T-cell Exhaustion During the Priming Phase of Immune Responses Against Breast Cancer Breast Cancer Research and Treatment. Apr, 2011 | Pubmed ID: 20480224 Tumour Secreted Grp170 Chaperones Full-length Protein Substrates and Induces an Adaptive Anti-tumour Immune Response in Vivo International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010 | Pubmed ID: 20210603 GM-CSF is One of the Main Breast Tumor-derived Soluble Factors Involved in the Differentiation of CD11b-Gr1- Bone Marrow Progenitor Cells into Myeloid-derived Suppressor Cells Breast Cancer Research and Treatment. Aug, 2010 | Pubmed ID: 19898981 IL-7 + IL-15 Are Superior to IL-2 for the Ex Vivo Expansion of 4T1 Mammary Carcinoma-specific T Cells with Greater Efficacy Against Tumors in Vivo Breast Cancer Research and Treatment. Jul, 2010 | Pubmed ID: 19826947 Human T Cells Express CD25 and Foxp3 Upon Activation and Exhibit Effector/memory Phenotypes Without Any Regulatory/suppressor Function Journal of Translational Medicine. 2009 | Pubmed ID: 19849846 Gemcitabine Directly Inhibits Myeloid Derived Suppressor Cells in BALB/c Mice Bearing 4T1 Mammary Carcinoma and Augments Expansion of T Cells from Tumor-bearing Mice International Immunopharmacology. Jul, 2009 | Pubmed ID: 19336265 Immune-induced Epithelial to Mesenchymal Transition in Vivo Generates Breast Cancer Stem Cells Cancer Research. Apr, 2009 | Pubmed ID: 19276366 Incubation of Antigen-sensitized T Lymphocytes Activated with Bryostatin 1 + Ionomycin in IL-7 + IL-15 Increases Yield of Cells Capable of Inducing Regression of Melanoma Metastases Compared to Culture in IL-2 Cancer Immunology, Immunotherapy : CII. Oct, 2009 | Pubmed ID: 19198835 Adoptive Transfer of HER2/neu-specific T Cells Expanded with Alternating Gamma Chain Cytokines Mediate Tumor Regression when Combined with the Depletion of Myeloid-derived Suppressor Cells Cancer Immunology, Immunotherapy : CII. Jun, 2009 | Pubmed ID: 18979098 Radiofrequency Thermal Ablation of Breast Tumors Combined with Intralesional Administration of IL-7 and IL-15 Augments Anti-tumor Immune Responses and Inhibits Tumor Development and Metastasis Breast Cancer Research and Treatment. Apr, 2009 | Pubmed ID: 18425677 Prostate-derived Ets Transcription Factor As a Favorable Prognostic Marker in Ovarian Cancer Patients International Journal of Cancer. Journal International Du Cancer. Sep, 2008 | Pubmed ID: 18567002 Does HER-2/neu Antigen Loss in Metastatic Breast Tumors Occur Under Immune Pressure? International Journal of Cancer. Journal International Du Cancer. Sep, 2008 | Pubmed ID: 18566999 Signatures Associated with Rejection or Recurrence in HER-2/neu-positive Mammary Tumors Cancer Research. Apr, 2008 | Pubmed ID: 18381452 Danger Signals and Nonself Entity of Tumor Antigen Are Both Required for Eliciting Effective Immune Responses Against HER-2/neu Positive Mammary Carcinoma: Implications for Vaccine Design Cancer Immunology, Immunotherapy : CII. Sep, 2008 | Pubmed ID: 18278493 Tumor Immunoediting and Immunosculpting Pathways to Cancer Progression Seminars in Cancer Biology. Aug, 2007 | Pubmed ID: 17662614 Come Forth 1E10 Anti-idiotype Vaccine: Delivering the Promise to Immunotherapy of Small Cell Lung Cancer Cancer Biology & Therapy. Feb, 2007 | Pubmed ID: 17426436 HER-2/neu Antigen Loss and Relapse of Mammary Carcinoma Are Actively Induced by T Cell-mediated Anti-tumor Immune Responses European Journal of Immunology. Mar, 2007 | Pubmed ID: 17304628 Heat Shock Proteins As Vaccine Adjuvants in Infections and Cancer Drug Discovery Today. Jun, 2006 | Pubmed ID: 16713905 Comment on "Tumor Progression Can Occur Despite the Induction of Very High Levels of Self/tumor Antigen-specific CD8+ T Cells in Patients with Melanoma" Journal of Immunology (Baltimore, Md. : 1950). Apr, 2006 | Pubmed ID: 16585536 Immunoadjuvant Chaperone, GRP170, Induces 'danger Signals' Upon Interaction with Dendritic Cells Immunology and Cell Biology. Apr, 2006 | Pubmed ID: 16519738 Chaperoning Function of Stress Protein Grp170, a Member of the Hsp70 Superfamily, is Responsible for Its Immunoadjuvant Activity Cancer Research. Jan, 2006 | Pubmed ID: 16424054 Emergence of Immune Escape Variant of Mammary Tumors That Has Distinct Proteomic Profile and a Reduced Ability to Induce "danger Signals" Breast Cancer Research and Treatment. Apr, 2006 | Pubmed ID: 16211331 Heat Shock Proteins HSP70 and GP96: Structural Insights Cancer Immunology, Immunotherapy : CII. Mar, 2006 | Pubmed ID: 16032399 HSP110 Induces "danger Signals" Upon Interaction with Antigen Presenting Cells and Mouse Mammary Carcinoma Immunobiology. 2005 | Pubmed ID: 16164037 Heat Shock Proteins and Scavenger Receptors: Role in Adaptive Immune Responses Immunological Investigations. 2005 | Pubmed ID: 16136784 Cancer Immunotherapy and Heat-shock Proteins: Promises and Challenges Expert Opinion on Biological Therapy. Mar, 2004 | Pubmed ID: 15006730 Development of Cancer Vaccines Using Autologous and Recombinant High Molecular Weight Stress Proteins Methods (San Diego, Calif.). Jan, 2004 | Pubmed ID: 14624871 HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice Journal of Immunology (Baltimore, Md. : 1950). Oct, 2003 | Pubmed ID: 14530326 Targeted Immunotherapy Using Reconstituted Chaperone Complexes of Heat Shock Protein 110 and Melanoma-associated Antigen Gp100 Cancer Research. May, 2003 | Pubmed ID: 12750279 Hsp110 Over-expression Increases the Immunogenicity of the Murine CT26 Colon Tumor Cancer Immunology, Immunotherapy : CII. Aug, 2002 | Pubmed ID: 12111119 Development of a Recombinant HSP110-HER-2/neu Vaccine Using the Chaperoning Properties of HSP110 Cancer Research. Mar, 2002 | Pubmed ID: 11912148 Immunotherapy of Cancer Using Heat Shock Proteins Frontiers in Bioscience : a Journal and Virtual Library. Jan, 2002 | Pubmed ID: 11779704 Expansão ex vivo de células tumorais T-reativa por Meios de 1/Ionomycin Bryostatin eo Common Gamma Cadeia Formulação Citocinas Maciej Kmieciak1, Amir Toor2, Laura Graham3, Harry D. Bear3, Masoud H. Manjili1 1Department of Microbiology & Immunology, Virginia Commonwealth University- Massey Cancer Center, 2Department of Internal Medicine, Virginia Commonwealth University- Massey Cancer Center, 3Department of Surgery, Virginia Commonwealth University- Massey Cancer Center JoVE 2381 Immunology and Infection
Expansão ex vivo de células tumorais T-reativa por Meios de 1/Ionomycin Bryostatin eo Common Gamma Cadeia Formulação Citocinas Maciej Kmieciak1, Amir Toor2, Laura Graham3, Harry D. Bear3, Masoud H. Manjili1 1Department of Microbiology & Immunology, Virginia Commonwealth University- Massey Cancer Center, 2Department of Internal Medicine, Virginia Commonwealth University- Massey Cancer Center, 3Department of Surgery, Virginia Commonwealth University- Massey Cancer Center JoVE 2381 Immunology and Infection
